Cargando…
Efficient fdCas9 Synthetic Endonuclease with Improved Specificity for Precise Genome Engineering
The Cas9 endonuclease is used for genome editing applications in diverse eukaryotic species. A high frequency of off-target activity has been reported in many cell types, limiting its applications to genome engineering, especially in genomic medicine. Here, we generated a synthetic chimeric protein...
Autores principales: | Aouida, Mustapha, Eid, Ayman, Ali, Zahir, Cradick, Thomas, Lee, Ciaran, Deshmukh, Harshavardhan, Atef, Ahmed, AbuSamra, Dina, Gadhoum, Samah Zeineb, Merzaban, Jasmeen, Bao, Gang, Mahfouz, Magdy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520497/ https://www.ncbi.nlm.nih.gov/pubmed/26225561 http://dx.doi.org/10.1371/journal.pone.0133373 |
Ejemplares similares
-
CRISPR/Cas9-mediated target validation of the splicing inhibitor Pladienolide B
por: Aouida, Mustapha, et al.
Publicado: (2016) -
Refining the migration and engraftment of short-term and long-term HSCs by enhancing homing-specific adhesion mechanisms
por: Al-Amoodi, Asma S., et al.
Publicado: (2022) -
An Analysis of Trafficking Receptors Shows that CD44 and P-Selectin Glycoprotein Ligand-1 Collectively Control the Migration of Activated Human T-Cells
por: Ali, Amal J., et al.
Publicado: (2017) -
Functional binding of E-selectin to its ligands is enhanced by structural features beyond its lectin domain
por: Aleisa, Fajr A., et al.
Publicado: (2020) -
Anti-CD44 antibodies inhibit both mTORC1 and mTORC2: a new rationale supporting CD44-induced AML differentiation therapy
por: Gadhoum, S Z, et al.
Publicado: (2016)